RWD6 COMPARATIVE ANALYSIS OF MEDICATION VALUE SETS ACROSS REFERENCE SOURCES TO ENSURE COMPLETE COVERAGE FOR REAL WORLD EVIDENCE STUDIES
Rattachement africain : us. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Objectives: As the world transitions into the endemic phase of COVID-19, a new challenge emerges: the long-term burden of illness among survivors.Health-related quality of life (HRQoL) outcomes remains poorly understood in low-and middleincome countries, where post-pandemic policy decisions lack localized evidence.This study aimed to map the trajectory of HRQoL recovery in a large cohort of Malaysian COVID-19 survivors and identify key sociodemographic and clinical predictors-critical inputs for value-based post-COVID care and pandemic preparedness.Methods: A prospective cohort study involving 2,000 recovered patients was conducted in Selangor, Malaysia.HRQoL was assessed at three intervals-during infection, 3 months, and 6 months post-discharge, using EQ-5D-5L (utility values) and COVID-19-Quality of Life (disease-specific).The CO-19-QoL tool was culturally adapted and validated in accordance with the Professional Society for Health Economics and Outcomes Research (ISPOR) guidelines, demonstrating high internal consistency (Cronbach's α=0.919) and test-retest reliability (ICC=0.896).General Linear Models and repeated measures ANOVA were used to examine HRQoL changes and associated factors.Results: EQ-5D utility scores improved from 0.33 6 0.19 (baseline) to 0.54 6 0.20 (6 months; p,0.001), and EQ-VAS scores rose from 45.50 to 86.38.CO-19-QoL scores declined from 19.49 to 1.89, indicating reduced symptom burden.However, recovery was uneven.Poorer HRQoL trajectories were significantly associated with older age ($ 60), comorbidities, lower education, private sector employment, overweight BMI, smoking, and severe COVID-19 (Category 4).Socioeconomic disparities were evident; low-income patients (B40) experienced the slowest recovery (p,0.001).Conclusions: While overall HRQoL improved, vulnerable groups faced persistent deficits, highlighting the need for targeted post-COVID rehabilitation and equity-driven policies.EQ-5D-derived utility values lay the groundwork for cost-utility analyses and health technology assessments in Malaysia.These findings provide critical evidence for post-pandemic planning and reinforce the importance of integrating HRQoL into future emergency preparedness frameworks.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- RWD6 COMPARATIVE ANALYSIS OF MEDICATION VALUE SETS ACROSS REFERENCE SOURCES TO ENSURE COMPLETE COVERAGE FOR REAL WORLD EVIDENCE STUDIES
- Date Crossref
- 01/10/2025
- Éditeur
- Elsevier BV
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Les institutions déclarées
Une affiliation ne permet pas de déduire la nationalité d’un auteur.